Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 12217 | Ordered by Date (descending)
1 2 3 ... 121 122 123  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. 2019-03-14
Cambrex Corporation. (3/14/19). "Press Release: Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan". East Rutherford, NJ. 2019-03-14
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. 2019-03-13
iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. 2019-03-12
Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. 2019-03-12
ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. 2019-03-12
Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. 2019-03-11
Tecan Group Ltd.. (3/11/19). "Press Release: Tecan Reports Strong Second Half and a Very Successful Fiscal Year 2018". Männedorf. 2019-03-11
Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden. 2019-03-08
SOM Biotech S.L.. (3/7/19). "Press Release: SOM Biotech Closes a Financing Round of 7m Euros". Barcelona. 2019-03-07
Gilde Healthcare Partners. (3/7/19). "Press Release: Gilde Healthcare Raises €200 Million for New Private Equity Fund. Targeting Lower Mid-market Healthcare Investments in the Benelux and DACH Regions". Utrecht & Frankfurt a. M.. 2019-03-07
Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA. 2019-03-06
Moderna, Inc.. (3/6/19). "Press Release: Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress". Cambridge, MA. 2019-03-06
Mersana Therapeutics, Inc.. (3/5/19). "Press Release: Mersana Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates". Cambridge, MA. 2019-03-05
Erasca, Inc.. (3/5/19). "Press Release: Erasca Announces Series A Extension, Bringing Total Round to $64 Million". San Diego, CA. 2019-03-05
Mersana Therapeutics, Inc.. (3/5/19). "Press Release: Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridge, MA. 2019-03-05
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives". 2019-03-05
Kiadis Pharma N.V.. (3/5/19). "Press Release: Kiadis Pharma Strengthens Management Team". Amsterdam. 2019-03-05
Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. 2019-03-05
Fluidigm Corporation. (3/5/19). "Press Release: Colin McCracken Joins Fluidigm as Chief Commercial Officer". South San Francisco, CA. 2019-03-05
Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma Announces Once-weekly TransCon Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency". 2019-03-04
Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. 2019-03-04
Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma A/S Announces Proposed Public Offering of ADSs". Copenhagen. 2019-03-04
Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". 2019-03-04
UCB S.A.. (3/1/19). "Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio". Brussels. 2019-03-01
Neurimmune AG. (3/1/19). "Press Release: Neurimmune Appoints John Dellapa as General Counsel". Schlieren. 2019-03-01
Seventure Partners. (3/1/19). "Press Release: Seventure Partners Life Sciences Corporate Update September 2018 – February 2019". Paris. 2019-03-01
iOnctura S.A.. (2/28/19). "Press Release: iOnctura Selected for an Oral Presentation at 2019 AACR Annual Meeting". Geneva. 2019-02-28
Uniqure N.V.. (2/28/19). "Press Release: Uniqure Announces 2018 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-02-28
UCB S.A.. (2/28/19). "Press Release: UCB Full Year Report 2018. 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB’s Strong Pipeline". Brussels. 2019-02-28
Centogene AG. (2/28/19). "Press Release: Centogene Announces Strategic Collaboration with Sarepta Therapeutics". Rostock. 2019-02-28
Argenx SE. (2/28/19). "Press Release: Argenx Reports Fourth Quarter Business Update and Full Year 2018 Financial Results". Breda & Ghent. 2019-02-28
CN Bio Innovations Ltd.. (2/27/19). "Press Release: CN Bio to Put Ten Organs on “Body-on-a-Chip”". London. 2019-02-27
MeiraGTx Holdings plc. (2/27/19). "Press Release: MeiraGTx Announces $80 Million Private Placement of Ordinary Shares". London & New York, NY. 2019-02-27
Merck KGaA. (2/27/19). "Press Release: Merck Submits All-Cash Proposal to Acquire Versum. $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-Stock Proposal". Darmstadt. 2019-02-27
Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. 2019-02-27
CureVac AG. (2/27/19). "Press Release: CEPI Awards US$ 34m Contract to CureVac to Advance the RNA Printer—a Disruptive, Transportable mRNA Vaccine Manufacturing Platform that Can Rapidly Combat Multiple Diseases". Oslo. 2019-02-27
MaRS Innovation. (2/27/19). "Press Release: MaRS Innovation Adds to Growing Portfolio with Two New LAB150 Projects to Create Novel Therapeutics for Cystic Fibrosis and Respiratory Syncytial Virus". Toronto, ON. 2019-02-27
Hookipa Pharma Inc.. (2/26/19). "Press Release: Hookipa Pharma Raises $37.4 Million (€33.2 Million) in Series D Financing". New York, NY & Vienna. 2019-02-26
Voyager Therapeutics, Inc.. (2/26/19). "Press Release: Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights". Cambridge, MA. 2019-02-26
Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". 2019-02-26
Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC. 2019-02-25
CRISPR Therapeutics AG. (2/25/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results". Zug & Cambridge, MA. 2019-02-25
Roche. (2/25/19). "Press Release: Roche Enters into Definitive Merger Agreement to Acquire Spark Therapeutics". Basel. 2019-02-25
Orchard Therapeutics Ltd.. (2/25/19). "Press Release: Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD". Boston, MA & London. 2019-02-25
Lonza Group AG. (2/25/19). "Press Release: Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment". Basel. 2019-02-25
Orchard Therapeutics Ltd.. (2/22/19). "Press Release: Orchard Therapeutics Presents Two-year Follow-up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID". Boston, MA & London. 2019-02-22
Voyager Therapeutics, Inc.. (2/22/19). "Press Release: Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson’s Disease and Other Synucleinopathies". Cambridge, MA & North Chicago, IL. 2019-02-22
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
BiomX Ltd.. (2/20/19). "Press Release: BiomX Raises $32 Million in Series B Financing. Proceeds Will Be Used Primarily to Advance Leading IBD and Acne Programs to the Clinic". Ness Ziona. 2019-02-20
BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. 2019-02-20
Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
CRISPR Therapeutics AG. (2/19/19). "Press Release: CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement". Zug, Cambridge, MA & Durham, NC. 2019-02-19
France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. 2019-02-19
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma". Basel. 2019-02-19
Merck KGaA. (2/19/19). "Press Release: Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method". Darmstadt. 2019-02-19
MDxHealth S.A.. (2/19/19). "Press Release: MDxHealth Appoints Michael K. McGarrity as CEO. Dr. Jan Groen Continues as an Advisor to the Board". Irvine, CA & Herstal. 2019-02-19
Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Personalised Medicine Entrectinib". Basel. 2019-02-19
Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2019-02-19
Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & 2019-02-16
Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. 2019-02-15
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. 2019-02-14
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. 2019-02-13
Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. 2019-02-13
TCR2 Therapeutics Inc.. (2/13/19). "Press Release: TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock". Cambridge, MA. 2019-02-13
Johnson & Johnson. (2/13/19). "Press Release: Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.". New Brunswick, NJ. 2019-02-13
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. 2019-02-12
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. 2019-02-12
Culture Biosciences, Inc.. (2/12/19). "Press Release: Culture Biosciences Secures $5.5m to Pioneer Biomanufacturing-as-a-Service". South San Francisco, CA. 2019-02-12
Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. 2019-02-12
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. 2019-02-11
Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-02-11
Bluebird Bio, Inc.. (2/11/19). "Press Release: Bluebird Bio Appoints Chip Baird as Chief Financial Officer". Cambridge, MA. 2019-02-11
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Uniqure N.V.. (2/8/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-02-08
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Co-marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations". South San Francisco, CA. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. 2019-02-07
Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. 2019-02-06
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. 2019-02-05
1 2 3 ... 121 122 123  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

» top